Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Pirani, TasneemWilson, Anthony
Brealey, David
Low, Ryan
O'Neill, Suzanne
Le, Jenny
Jhanji, Shaman
Bangash, Mansoor N
Mathew, Amrith
Wright, Christopher
Latif, Anne-Louise
Irvine, David
Kasipandian, Vidya
Singh, Neeraj
Saha, Rohit
Metaxa, Victoria
Publication date
2024-03-22
Metadata
Show full item recordAbstract
Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UKCitation
Pirani T, Wilson A, Brealey D, Low R, O'Neill S, Le J, Jhanji S, Bangash MN, Mathew A, Wright C, Latif AL, Irvine D, Kasipandian V, Singh N, Saha R, Metaxa V. Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK. Br J Anaesth. 2024 May;132(5):1004-1006. doi: 10.1016/j.bja.2024.01.047. Epub 2024 Mar 22.Type
ArticlePMID
38521658Journal
British Journal of AnaesthesiaPublisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/j.bja.2024.01.047